Provided by Tiger Trade Technology Pte. Ltd.

CVRx, Inc.

1.75
-0.8800-33.46%
Post-market: 1.71-0.0399-2.28%17:56 EDT
Volume:4.26M
Turnover:8.45M
Market Cap:46.62M
PE:-0.89
High:2.65
Open:2.63
Low:1.65
Close:2.63
52wk High:11.30
52wk Low:1.65
Shares:26.64M
Float Shares:15.55M
Volume Ratio:8.90
T/O Rate:27.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9748
EPS(LYR):-2.0436
ROE:-133.44%
ROA:-28.70%
PB:2.34
PE(LYR):-0.86

Loading ...

CVRx to Present Late-Breaking Rebalance Registry Real-World Barostim Outcomes at HFSA 2026

Reuters
·
Yesterday

Wall Street Analysts Are Neutral on Top Healthcare Picks

TIPRANKS
·
Sep 23

Analysts’ Opinions Are Mixed on These Healthcare Stocks: CVRx (CVRX), Butterfly Network (BFLY) and Viridian Therapeutics (VRDN)

TIPRANKS
·
Sep 22

CVRx appoints veteran medtech executive as new CFO

TIPRANKS
·
Sep 22

Nyxoah Names Loic Moreau Interim CFO as John Landry Steps Down

MT Newswires Live
·
Sep 22

CVRx Names New Chief Financial Officer

MT Newswires Live
·
Sep 22

CVRx appoints John Landry as CFO

TIPRANKS
·
Sep 22

CVRx Names Nyxoah CFO John Landry as Finance Chief

Reuters
·
Sep 22

CVRx Appoints John Landry as Chief Financial Officer

THOMSON REUTERS
·
Sep 22

CVRx, - John Landry to Join CVRx on Oct 12, 2026 and Assume CFO Role After Q3 10-Q Filing

THOMSON REUTERS
·
Sep 22

CVRx’s BAROSTIM Registry: Real‑World Hypertension Data That Could Move the Stock

TIPRANKS
·
Sep 12

BAROSTIM NEO Trial Update: Long-Term Hypertension Data in Focus for CVRX Investors

TIPRANKS
·
Sep 12

CVRx Says Board Reviews Options After Pointillist Letter, Sees Barostim Undervalued

Reuters
·
Aug 25

CVRx, Inc.: Board is Open to Constructive Engagement with All of Its Shareholders

THOMSON REUTERS
·
Aug 25

CVRx, - Board Regularly Evaluates Options to Maximize Shareholder Value

THOMSON REUTERS
·
Aug 25

CVRx Responds to Letter from Pointillist Family Office

GlobeNewswire
·
Aug 25

CVRx Shareholder Chernett Urges Board to Start Immediate Sale Process to Strategic Buyer

Reuters
·
Aug 24

Jorey Chernett, Owner of More than 5.5% of Outstanding Shares of CVRx, Calls on Board to Begin Immediate Process to Pursue Sale of the Company to a Strategic Acquirer

THOMSON REUTERS
·
Aug 24

Jorey Chernett: Calls on CVRx Board Initiate a Comprehensive Review of Strategic Alternatives

THOMSON REUTERS
·
Aug 24

CVRx Announces Devoted Health Medicare Advantage Coverage Policy for Barostim Therapy

THOMSON REUTERS
·
Aug 24